Gland Pharma Ltd.NSE: GLAND

Press Release Jun 04 2025

· Issued by Gland Pharma Ltd.

Filed with NSE ·

Gland Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2025, titled "Gland Pharma receives approval from the United States Foodand Drug Administration (USFDA) for Angiotensin II Acetate Injection 2.5 mg/mL".

View Attachment

6ix hasn’t read this filing yet.

Gland Pharma Ltd. on 6ix

Earlier from Gland Pharma

Later from Gland Pharma

All Gland Pharma news releases